0000731012-26-000009
SEC filingHealthcare Services Group, Inc. (HCSG) reported FY 2025 revenues of $1.84B, with costs of services provided at $1.60B and selling, general and administrative expenses of $190.9M. Investment and other income, net contributed $20.9M, while interest expense was $1.6M, leading to income before taxes of $67.9M and net income of $59.1M after an $8.8M tax provision. Basic and diluted EPS both reached $1, supported by 72.4M basic and 73.0M diluted shares. Total comprehensive income was $60.9M, including $1.9M unrealized gain on marketable securities. Balance sheet shows total assets of $794.3M, with $576.4M current assets including $125.2M cash and $281.3M accounts receivable. Stockholders' equity stands at $510.2M. Operating cash flow was robust at $145.0M, investing cash flow -$11.0M, financing -$63.3M including $61.6M treasury stock purchases, yielding a $70.6M net increase in cash and equivalents. Strong liquidity and profitability position HCSG for growth in healthcare services.
Healthcare Services Group, Inc. (HCSG) delivered FY 2025 results with revenues of $1.84B and net income of $59.1M. Income before taxes was $67.9M after $1.60B costs of services, $190.9M SG&A, $20.9M investment income, and -$1.6M interest expense. Income tax provision was $8.8M. Basic EPS was $1 on 72.4M shares, diluted EPS $1 on 73.0M shares. Total comprehensive income reached $60.9M, including $1.9M unrealized gain on securities. Total assets grew to $794.3M with stockholders' equity at $510.2M. No prior year figures disclosed in filing.
Revenues totaled $1.84B for the period ending 2025-12-31. Filing provides no segment breakdown, geographic mix, or growth drivers. Costs of services provided were $1.60B. No additional revenue composition details available.
Gross profit calculable as revenues $1.84B minus costs of services $1.60B, yielding $240M or 13.0% gross margin. Operating profitability reflected in $67.9M pre-tax income. SG&A expenses $190.9M. Investment income $20.9M offset minor interest expense. No margin trends or cost structure changes disclosed versus prior periods.
Net cash from operating activities was $145.0M, driven by $59.1M net income, $83.1M bad debt provision, $19.2M deferred taxes, and $16.8M depreciation. Investing activities used -$11.0M, including $7.2M acquisition and net marketable securities activity. Financing activities -$63.3M, primarily $61.6M treasury stock purchases. Net increase in cash, equivalents, and restricted: $70.6M. Balance sheet: $125.2M cash, $576.4M current assets, $170.4M current liabilities. Total equity $510.2M. Cash paid for interest: $1.7M.
Filing contains no management guidance, strategic priorities, or risk factors disclosure in provided content.